OXiGENE is a biopharmaceutical company whose mission is finding and developing new and improved therapeutics that can deliver significant medical benefits to patients with cancer and sight-threatening eye diseases and conditions.
Friday, March 7, 2014
OXiGENE Announces Presentation at the ROTH Conference on March 11, 2014
Tuesday, March 4, 2014
OXiGENE Announces Full Year 2013 Earnings Conference Call and Webcast